BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Siyah P, Kocabaş F. (2024) Isolation of Human Hematopoietic Stem Cells from an Apheresis Sample. Methods in Molecular Biology (Clifton, N.J.) |
| Comert Onder F, Siyah P, Durdagi S, et al. (2022) Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy. Rsc Medicinal Chemistry. 13: 840-849 |
| Siyah P, Akgol S, Durdagi S, et al. (2021) Identification of first-in-class plasmodium OTU inhibitors with potent anti-malarial activity. The Biochemical Journal |
| Uslu M, Siyah P, Harvey AJ, et al. (2021) Modulating Cas9 activity for precision gene editing. Progress in Molecular Biology and Translational Science. 181: 89-127 |
| Turan RD, Albayrak E, Uslu M, et al. (2020) Development of Small Molecule MEIS Inhibitors that modulate HSC activity. Scientific Reports. 10: 7994 |
| Aksoz M, Albayrak E, Aslan GS, et al. (2018) c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression. Current Cancer Drug Targets |